Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Arrhythmias

  Free Subscription


31.05.2021

3 Am Heart J
1 BMJ
1 Cardiovasc Res
1 Chest
1 Circ Genom Precis Med
1 Clin Cardiol
14 Eur Heart J
3 Heart
37 Int J Cardiol
6 J Cardiovasc Electrophysiol
2 J Electrocardiol
2 J Thorac Cardiovasc Surg
1 J Thromb Thrombolysis
6 N Engl J Med
3 Pacing Clin Electrophysiol
2 Resuscitation


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am Heart J

  1. KITTIPIBUL V, Blumer V, Hernandez GA, Fudim M, et al
    Pre-operative Atrial Fibrillation and Early Right Ventricular Failure after Left Ventricular Assist Device Implantation: A Systematic Review and Meta-Analysis.
    Am Heart J. 2021 May 23. pii: S0002-8703(21)00138.
    PubMed         Abstract available

  2. YAO X, Attia ZI, Behnken EM, Walvatne K, et al
    Batch Enrollment for an Artificial Intelligence-Guided Intervention to Lower Neurologic Events in Patients with Undiagnosed Atrial Fibrillation (BEAGLE): Rationale and design of a digital clinical trial.
    Am Heart J. 2021 May 22. pii: S0002-8703(21)00135.
    PubMed         Abstract available

  3. HESS PL, Gosch KL, Jani SM, Varosy PD, et al
    Use of Oral Anticoagulants in Patients with Valvular Atrial Fibrillation: Findings From the NCDR PINNACLE Registry(R).
    Am Heart J. 2021 May 22. pii: S0002-8703(21)00120.
    PubMed         Abstract available


    BMJ

  4. PERRY M, Kemmis Betty S, Downes N, Andrews N, et al
    Atrial fibrillation: diagnosis and management-summary of NICE guidance.
    BMJ. 2021;373:n1150.
    PubMed        


    Cardiovasc Res

  5. WIEDMANN F, Beyersdorf C, Zhou XB, Kraft M, et al
    Treatment of atrial fibrillation with doxapram: TASK-1 potassium channel inhibition as a novel pharmacological strategy.
    Cardiovasc Res. 2021 May 24. pii: 6283579. doi: 10.1093.
    PubMed         Abstract available


    Chest

  6. PROIETTI M, Romiti GF
    Management of Ventricular Heart Rate in Atrial Fibrillation Patients With Sepsis.
    Chest. 2021;159:1315-1316.
    PubMed        


    Circ Genom Precis Med

  7. O'SULLIVAN JW, Shcherbina A, Justesen JM, Turakhia M, et al
    Combining Clinical and Polygenic Risk Improves Stroke Prediction Among Individuals with Atrial Fibrillation.
    Circ Genom Precis Med. 2021 May 24. doi: 10.1161/CIRCGEN.120.003168.
    PubMed         Abstract available


    Clin Cardiol

  8. ECCLESTON DS, Kim JM, Ten Berg JM, Steg PG, et al
    The effect of sex on the efficacy and safety of dual antithrombotic therapy with dabigatran versus triple therapy with warfarin after PCI in patients with atrial fibrillation (a RE-DUAL PCI subgroup analysis and comparison to other dual antithrombotic
    Clin Cardiol. 2021 May 27. doi: 10.1002/clc.23649.
    PubMed         Abstract available


    Eur Heart J

  9. BENN M
    Atrial Fibrillation And Chronic Kidney Disease.
    Eur Heart J. 2021 May 23. pii: 6282434. doi: 10.1093.
    PubMed        

  10. PARK S, Lee S, Kim Y, Lee Y, et al
    Atrial fibrillation and kidney function: a bidirectional Mendelian randomization study.
    Eur Heart J. 2021 May 23. pii: 6282432. doi: 10.1093.
    PubMed         Abstract available

  11. KHURSHID S, Weng LC, Al-Alusi MA, Halford JL, et al
    Accelerometer-derived physical activity and risk of atrial fibrillation.
    Eur Heart J. 2021 May 25. pii: 6283622. doi: 10.1093.
    PubMed         Abstract available

  12. SCHNEEWEIS C, Ahrens I, Saygili E, Steven D, et al
    Cardiac involvement in sarcoidosis and necessary ventricular tachycardia ablation.
    Eur Heart J. 2021;42:544.
    PubMed        

  13. SAWANO S, Nakayama A, Morita H, Komuro I, et al
    Rathke's cleft cyst induced cardiac arrest.
    Eur Heart J. 2021;42:714.
    PubMed        

  14. IRIART X, Metras A, Coiffic A, Thambo JB, et al
    Late device-related thrombus after left atrial appendage closure: never let your guard down.
    Eur Heart J. 2021;42:1050.
    PubMed        

  15. KITE TA, Gershlick AH
    High-risk NSTE-ACS: high time for robust data.
    Eur Heart J. 2021;42:352.
    PubMed        

  16. CICONTE G, Monasky MM, Santinelli V, Micaglio E, et al
    Brugada syndrome genetics is associated with phenotype severity.
    Eur Heart J. 2021;42:1082-1090.
    PubMed         Abstract available

  17. CAO D, Chandiramani R, Chiarito M, Claessen BE, et al
    Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey.
    Eur Heart J. 2020 Dec 26. pii: 6050475. doi: 10.1093.
    PubMed         Abstract available

  18. CRIJNS HJGM, Prinzen F, Lambiase PD, Sanders P, et al
    The year in cardiovascular medicine 2020: arrhythmias.
    Eur Heart J. 2021;42:499-507.
    PubMed         Abstract available

  19. BEHR ER, Ben-Haim Y, Ackerman MJ, Krahn AD, et al
    Brugada syndrome and reduced right ventricular outflow tract conduction reserve: a final common pathway?
    Eur Heart J. 2021;42:1073-1081.
    PubMed         Abstract available

  20. POSTEMA PG, Walsh R, Bezzina CR
    Illuminating the path from genetics to clinical outcome in Brugada syndrome.
    Eur Heart J. 2021;42:1091-1093.
    PubMed        

  21. PAPPONE C, Ciconte G, Micaglio E, Monasky MM, et al
    Common modulators of Brugada syndrome phenotype do not affect SCN5A prognostic value.
    Eur Heart J. 2021;42:1273-1274.
    PubMed        

  22. EL-BATTRAWY I, Lang S, Zhou X, Akin I, et al
    Different genotypes of Brugada syndrome may present different clinical phenotypes: electrophysiology from bench to bedside.
    Eur Heart J. 2021;42:1270-1272.
    PubMed        


    Heart

  23. NICOLI CD, O'Neal WT, Levitan EB, Singleton MJ, et al
    Atrial fibrillation and risk of incident heart failure with reduced versus preserved ejection fraction.
    Heart. 2021 May 24. pii: heartjnl-2021-319122. doi: 10.1136/heartjnl-2021-319122
    PubMed         Abstract available

  24. KAWAJI T, Ogawa H, Hamatani Y, Kato M, et al
    Association of inverted T wave during atrial fibrillation rhythm with subsequent cardiac events.
    Heart. 2021 May 26. pii: heartjnl-2021-319199. doi: 10.1136/heartjnl-2021-319199
    PubMed         Abstract available

  25. WILDE AAM, Amin AS, Postema PG
    Diagnosis, management and therapeutic strategies for congenital long QT syndrome.
    Heart. 2021 May 26. pii: heartjnl-2020-318259. doi: 10.1136/heartjnl-2020-318259
    PubMed         Abstract available


    Int J Cardiol

  26. STRAW S, Witte KK
    Closing the loop: Delivering personalised care for patients with cryptogenic stroke.
    Int J Cardiol. 2021;327:100-101.
    PubMed        

  27. KAWAMATSU N, Ishizu T, Machino-Ohtsuka T, Masuda K, et al
    Direct oral anticoagulant use and outcomes in adult patients with Fontan circulation: A multicenter retrospective cohort study.
    Int J Cardiol. 2021;327:74-79.
    PubMed         Abstract available

  28. KO J, Koshy AN, Han HC, Weinberg L, et al
    Effect of liver transplantation on QT-interval prolongation and impact on mortality.
    Int J Cardiol. 2021;326:158-163.
    PubMed         Abstract available

  29. DE HEIDE J, de Wit A, Bhagwandien RE, Assaf A, et al
    Efficacy and safety of direct oral anticoagulants in patients undergoing elective electrical cardioversion: A real-world patient population.
    Int J Cardiol. 2021;326:98-102.
    PubMed         Abstract available

  30. NARAYAN P, Angelini GD
    Warm blood or cold cardioplegia- Is this the final answer?
    Int J Cardiol. 2021;322:99-100.
    PubMed        

  31. GATZOULIS KA, Arsenos P, Antoniou CK, Dilaveris P, et al
    Signal-averaged electrocardiogram findings among right ventricular arrhythmogenic cardiomyopathy (ARVC) patients: Do they have a place in ARVC management?
    Int J Cardiol. 2021;322:175.
    PubMed        

  32. CAMELI M, Pastore MC, Mandoli GE
    Left atrial strain: A key element for the evaluation of patients with HFpEF.
    Int J Cardiol. 2021;323:197-198.
    PubMed        

  33. ISBISTER JC, Nowak N, Butters A, Yeates L, et al
    "Concealed cardiomyopathy" as a cause of previously unexplained sudden cardiac arrest.
    Int J Cardiol. 2021;324:96-101.
    PubMed         Abstract available

  34. SCALLY C, Choo W, Rudd A, Neil C, et al
    The early dynamic of ECG in takotsubo syndrome presenting with ST-elevation: A comparison with age and gender-matched ST-elevation myocardial infarction.
    Int J Cardiol. 2020 Sep 10. pii: S0167-5273(20)33804.
    PubMed        

  35. BREITENSTEIN A, Saguner AM, Gasperetti A, Hofer D, et al
    Assessment of injury current during leadless pacemaker implantation.
    Int J Cardiol. 2021;323:113-117.
    PubMed         Abstract available

  36. ZHANG X, Jin Q, Kong D, Jiang Y, et al
    Comparison of fluoroscopy and transesophageal echocardiogram for intra-procedure device surveillance assessment during implantation of Watchman.
    Int J Cardiol. 2021;324:72-77.
    PubMed         Abstract available

  37. ANILKUMAR A, Moore EJ, Gall AJ, Sammut E, et al
    QTc interval in survivors of out of hospital cardiac arrest.
    Int J Cardiol. 2021;323:118-123.
    PubMed         Abstract available

  38. KUSCHYK J, Muller-Leisse J, Duncker D, Tulumen E, et al
    Comparison of transvenous vs subcutaneous defibrillator therapy in patients with cardiac arrhythmia syndromes and genetic cardiomyopathies.
    Int J Cardiol. 2021;323:100-105.
    PubMed         Abstract available

  39. MADIAS JE
    Electrocardiogram features and course in patients with takotsubo syndrome.
    Int J Cardiol. 2021;324:22.
    PubMed        

  40. HWANG J, Lee SR, Park HS, Lee YS, et al
    Adherence to dabigatran and the influence of dabigatran-induced gastrointestinal discomfort in the real-world practice.
    Int J Cardiol. 2021;323:77-82.
    PubMed         Abstract available

  41. SCOGNAMIGLIO G, Fusco F, Hankel TC, Bouma BJ, et al
    Safety and efficacy of non-vitamin K antagonist oral anticoagulants for prevention of thromboembolism in adults with systemic right ventricle: Results from the NOTE international registry.
    Int J Cardiol. 2021;322:129-134.
    PubMed         Abstract available

  42. LEE AC, Strugnell W, Vittinghoff E, Hamilton-Craig C, et al
    Electrophysiologic and imaging evidence for an occult myopathic substrate in patients with idiopathic ventricular arrhythmias.
    Int J Cardiol. 2021 May 25. pii: S0167-5273(21)00898.
    PubMed         Abstract available

  43. FRANKE KB, Marshall H, Kennewell P, Pham HD, et al
    Risk and predictors of sudden death in cardiac sarcoidosis: A systematic review and meta-analysis.
    Int J Cardiol. 2021;328:130-140.
    PubMed         Abstract available

  44. KHARBANDA RK, Lodder L, Ragab AAY, de Jong PL, et al
    Early and late post-operative arrhythmias after surgical myectomy: 45 years of follow-up.
    Int J Cardiol. 2021;328:63-68.
    PubMed         Abstract available

  45. MOLLER S
    Prolonged QT-interval in cirrhosis: is it reversible?
    Int J Cardiol. 2021;329:113-114.
    PubMed        

  46. DILAVERIS P, Tsioufis C
    The single-lead 14-day ECG patch EZYPRO(R): a new kid in the block.
    Int J Cardiol. 2021;332:89-90.
    PubMed        

  47. LIU CM, Chang SL, Yeh YH, Chung FP, et al
    Enhanced detection of cardiac arrhythmias utilizing 14-day continuous ECG patch monitoring.
    Int J Cardiol. 2021;332:78-84.
    PubMed         Abstract available

  48. KRISHNAPPA D, Wang W, Rooney MR, Norby FL, et al
    Life's Simple 7 cardiovascular health score and premature atrial contractions: The atherosclerosis risk in communities (ARIC) study.
    Int J Cardiol. 2021 Mar 3. pii: S0167-5273(21)00394.
    PubMed         Abstract available

  49. SHIN SY, Park JW
    Is the Left Atrial Appendage (LAA) anatomical shape really meaningless measure for stroke risk assessment?
    Int J Cardiol. 2021;330:80-81.
    PubMed        

  50. DI FLORIO A, Fusi C, Anselmi F, Cavigli L, et al
    Clinical management of young competitive athletes with premature ventricular beats: A prospective cohort study.
    Int J Cardiol. 2021;330:59-64.
    PubMed         Abstract available

  51. LIANG D, Shi R, Zheng KI, Zhou X, et al
    Clinical characteristics and outcomes in patients with echocardiographic left ventricular spontaneous echo contrast.
    Int J Cardiol. 2021;330:245-250.
    PubMed         Abstract available

  52. BARISON A, Baritussio A, Cipriani A, De Lazzari M, et al
    Cardiovascular magnetic resonance: What clinicians should know about safety and contraindications.
    Int J Cardiol. 2021;331:322-328.
    PubMed         Abstract available

  53. VOSKOBOINIK A, McDonald C, Chieng D, O'Brien J, et al
    Acute electrical, autonomic and structural effects of binge drinking: Insights into the 'holiday heart syndrome'.
    Int J Cardiol. 2021;331:100-105.
    PubMed         Abstract available

  54. NOURAEI H, Rabkin SW
    A new approach to the clinical subclassification of heart failure with preserved ejection fraction.
    Int J Cardiol. 2021 Jan 30. pii: S0167-5273(21)00134.
    PubMed         Abstract available

  55. CHEN T, Liu G, Mu Y, Xu WH, et al
    Application of cardiac computed tomographic imaging and fluoroscopy fusion for guiding left atrial appendage occlusion.
    Int J Cardiol. 2021;331:289-295.
    PubMed         Abstract available

  56. BAY M, Vollenweider P, Marques-Vidal P, Schlapfer J, et al
    Clinical factors associated with the intraventricular conduction disturbances in Swiss middle-aged adults: The CoLaus|PsyCoLaus study.
    Int J Cardiol. 2021;327:201-208.
    PubMed         Abstract available

  57. ISAKSEN JL, Ghouse J, Graff C, Olesen MS, et al
    Electrocardiographic T-wave morphology and risk of mortality.
    Int J Cardiol. 2021;328:199-205.
    PubMed         Abstract available

  58. FREDGART MH, Lindholt JS, Brandes A, Steffensen FH, et al
    Prognostic importance of left atrial size measured by non-contrast cardiac computed tomography - A DANCAVAS study.
    Int J Cardiol. 2021;328:220-226.
    PubMed         Abstract available

  59. FENDER AC, Dobrev D
    Potential antiarrhythmic actions of anticoagulants: Do they exist and can they be clinically unmasked?
    Int J Cardiol. 2021;331:73-74.
    PubMed        

  60. WALSH R
    Desmin variants in cardiomyopathies - the hard yards in defining pathogenicity.
    Int J Cardiol. 2021;331:208-209.
    PubMed        

  61. DUDZINSKA-SZCZERBA K, Michalowska I, Piotrowski R, Sikorska A, et al
    Assessment of the left atrial appendage morphology in patients after ischemic stroke - The ASSAM study.
    Int J Cardiol. 2021 Jan 29. pii: S0167-5273(21)00080.
    PubMed         Abstract available

  62. SEGGEWISS H, Batzner A
    Surgical myectomy in HOCM: Still gold standard for septal reduction?
    Int J Cardiol. 2021;331:174-175.
    PubMed        


    J Cardiovasc Electrophysiol

  63. LAI Y, Liu X, Sang C, Long D, et al
    Effectiveness of Ethanol infusion into the vein of Marshall combined with a fixed anatomical ablation strategy (the 'upgraded 2C3L' approach) for catheter ablation of persistent atrial fibrillation.
    J Cardiovasc Electrophysiol. 2021 May 24. doi: 10.1111/jce.15108.
    PubMed         Abstract available

  64. WANG YJ, Tian Y, Shi L, Zeng LJ, et al
    Pulmonary Vein Isolation Guided by Moderate Ablation Index Targets Combined with Strict Procedural Endpoints for Patients with Paroxysmal Atrial Fibrillation.
    J Cardiovasc Electrophysiol. 2021 May 24. doi: 10.1111/jce.15106.
    PubMed         Abstract available

  65. NAKASHIMA T, Nagase M, Shibahara T, Ono D, et al
    Another mechanism of atrial fibrillation initiation?
    J Cardiovasc Electrophysiol. 2021 May 24. doi: 10.1111/jce.15110.
    PubMed        

  66. YVOREL C, Da Costa A, Lerebours C, Guichard JB, et al
    Comparison of Clockwise and Counterclockwise Right Atrial Flutter Using High Resolution Mapping and Automated Velocity Measurements.
    J Cardiovasc Electrophysiol. 2021 May 26. doi: 10.1111/jce.15111.
    PubMed         Abstract available

  67. MCGILVRAY MMO, Bakir NH, Kelly MO, Perez SC, et al
    Efficacy of the Stand-Alone Cox-Maze IV Procedure in Patients with Longstanding Persistent Atrial Fibrillation.
    J Cardiovasc Electrophysiol. 2021 May 26. doi: 10.1111/jce.15113.
    PubMed         Abstract available

  68. SZILI-TOROK T, Kis Z, Bhagwandien R, Wijchers S, et al
    Functional Electrographic Flow Patterns in Patients with Persistent Atrial Fibrillation Predict Outcome of Catheter Ablation.
    J Cardiovasc Electrophysiol. 2021 May 26. doi: 10.1111/jce.15115.
    PubMed         Abstract available


    J Electrocardiol

  69. HUNG LT, Alshareef A, Al-Ahdal TMA, Anh PTT, et al
    Predicting atrial fibrillation after cardiac surgery using a simplified risk index.
    J Electrocardiol. 2021;67:45-49.
    PubMed         Abstract available

  70. LILJEGREN F, Svennberg E, Frykman V, Engdahl J, et al
    Progression and clinical manifestations in screening-detected atrial fibrillation: A follow-up of the STROKESTOP study.
    J Electrocardiol. 2021;67:33-38.
    PubMed         Abstract available


    J Thorac Cardiovasc Surg

  71. CHEN S, Grossi EA
    Commentary: New onset atrial fibrillation: Not just a nuisance.
    J Thorac Cardiovasc Surg. 2021 Apr 20. pii: S0022-5223(21)00611.
    PubMed        

  72. MACGREGOR RM, Bakir NH, Pedamallu H, Sinn LA, et al
    Late results after stand-alone surgical ablation for atrial fibrillation.
    J Thorac Cardiovasc Surg. 2021 Apr 17. pii: S0022-5223(21)00668.
    PubMed         Abstract available


    J Thromb Thrombolysis

  73. PIAZZA G, Hurwitz S, Goldhaber SZ
    Stroke risk factors and outcomes among hospitalized women with atrial fibrillation.
    J Thromb Thrombolysis. 2021 May 26. pii: 10.1007/s11239-021-02482.
    PubMed         Abstract available


    N Engl J Med

  74. PROIETTI R, Vio R, Lip GYH
    Cryoablation as Initial Therapy for Atrial Fibrillation.
    N Engl J Med. 2021;384:e82.
    PubMed        

  75. DIMARCO A, Lavesa-Cesana J
    Cryoablation as Initial Therapy for Atrial Fibrillation.
    N Engl J Med. 2021;384:e82.
    PubMed        

  76. GALES L, Lipsker D
    Cryoablation as Initial Therapy for Atrial Fibrillation.
    N Engl J Med. 2021;384:e82.
    PubMed        

  77. ANDRADE JG, Deyell MW, Verma A
    Cryoablation as Initial Therapy for Atrial Fibrillation. Reply.
    N Engl J Med. 2021;384:e82.
    PubMed        

  78. WAZNI OM, Sood N, Nissen SE
    Cryoablation as Initial Therapy for Atrial Fibrillation. Reply.
    N Engl J Med. 2021;384:e82.
    PubMed        

  79. MARINE JE
    Cryoablation as Initial Therapy for Atrial Fibrillation. Reply.
    N Engl J Med. 2021;384:e82.
    PubMed        


    Pacing Clin Electrophysiol

  80. SULKE N, Dulai R, Freemantle N, Sugihara C, et al
    Long Term outcomes of percutaneous atrial fibrillation ablation in patients with continuous monitoring.
    Pacing Clin Electrophysiol. 2021 May 24. doi: 10.1111/pace.14282.
    PubMed         Abstract available

  81. SASSONE B, Virzi S, Bertini M, Pasanisi G, et al
    Impact of the COVID-19 lockdown on the arrhythmic burden of patients with implantable cardioverter-defibrillators.
    Pacing Clin Electrophysiol. 2021 May 22. doi: 10.1111/pace.14280.
    PubMed         Abstract available

  82. MIYAZAKI Y, Noda T, Miyamoto K, Nagase S, et al
    Narrow QRS complex tachycardia with a 2:1 atrioventricular block: What is the mechanism.
    Pacing Clin Electrophysiol. 2021 May 22. doi: 10.1111/pace.14279.
    PubMed        


    Resuscitation

  83. BRESESTI I, Avian A, Bruckner M, Binder-Heschl C, et al
    Impact of bradycardia and hypoxemia on oxygenation in preterm infants requiring respiratory support at birth.
    Resuscitation. 2021 May 25. pii: S0300-9572(21)00184.
    PubMed         Abstract available

  84. NAS J, Thannhauser J, van Dijk EGJA, Verkroost C, et al
    Coronary angiography findings in patients with shock-resistant ventricular fibrillation cardiac arrest.
    Resuscitation. 2021 May 20. pii: S0300-9572(21)00187.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: